News And Updates
Collaboration Expands Testing Options, Launches Collaborative Hub in Austin, Texas
Austin, Texas – January 8, 2025 – Fagron Genomics US, a leader in advanced genetic testing and interpretation, today announced a groundbreaking partnership with ExtendingME, a Florida-based, premier personalized genetics laboratory specializing in longevity support. This collaboration not only expands Fagron Genomics’ testing portfolio but also launches new market opportunities in personalized medicine, as well as an innovative hub for collaboration among novel companies in the field.
Through this partnership, Fagron Genomics US will introduce ExtendingME’s comprehensive Epigenetics Report, Extensive Disease Risk Management Report, and Blood Biomarkers Report into its testing menu. Designed by ExtendingME, these tools provide a detailed understanding of a patient’s biological age and overall health trajectory, empowering healthcare providers to recommend targeted interventions that promote healthy aging. By integrating these reports into its offerings, Fagron Genomics US hopes to deliver actionable insights that enable patients to take control of their health and longevity.
As part of its mission to advance precision medicine, Fagron Genomics will also be introducing a new collaborative initiative in Austin, Texas. This partnership aims to offer advanced infrastructure and shared resources to help emerging companies accelerate growth while reducing costs. Designed with scalability and synergy in mind, the hub will include flexible spaces for expansion, access to advanced testing equipment, shared professional services, and operational cost efficiencies. Participants will also benefit from Fagron Genomics’ leadership guidance, technical oversight, and digital marketing expertise aimed at enhancing their strategic and market reach.
This collaborative environment will foster creativity, innovation, and mutual success, inviting forward-thinking companies in personalized medicine to join forces in shaping the future of healthcare.
“This partnership and collaborative hub reflect Fagron Genomics’ experience in supporting both large labs and small personalized markets. In personalized testing, scalability and efficiency are major challenges, especially for startups without significant capital.” said Michael Willoughby, President of Fagron Genomics US. “This initiative is designed to help small companies thrive by providing shared resources and infrastructure.”
Bobby Garcia, VP of Sales at ExtendingME, added, “At ExtendingME, we are committed to providing healthcare providers with the tools they need to redefine longevity and wellness for their patients. Partnering with Fagron Genomics US allows us to extend the reach of our cutting-edge Epigenetics Report and educational support to a wider audience, empowering providers to deliver personalized, actionable care. Together, we are pushing the boundaries of precision medicine to make a measurable difference in patients’ lives.”
This partnership comes at a pivotal moment for the healthcare industry, as the demand for personalized and preventative care solutions continues to rise. By combining ExtendingME’s innovative test offerings with Fagron Genomics US’ proven expertise in genetic testing, interpretation, and educational support, the two labs aim to bridge the gap between advanced science and practical application, empowering providers to meet the evolving needs of their patients.
The partnership is set to launch in the coming months, with the new test panels, educational resources, and collaborative opportunities becoming available to providers and companies nationwide.
For more information, or to inquire about joining the collaborative, visit www.fagrongenomicsus.com